EKF Diagnostics Holdings plc

EKF Diagnostics Holdings plc EKF

Dividend Summary

The next EKF Diagnostics Holdings plc dividend is expected to go ex in 5 months and to be paid in 6 months.
The previous EKF Diagnostics Holdings plc dividend was 1.1p and it went ex 7 months ago and it was paid 6 months ago.
There is typically 1 dividend per year (excluding specials), and the dividend cover is approximately 2.0.

Latest Dividends
Summary Previous dividend Next dividend
Status Paid Forecast
Type Final Final
Per share 1.1p Sign Up Required
Declaration date 30 Mar 2021 (Tue)
Ex-div date 04 Nov 2021 (Thu) 03 Nov 2022 (Thu)
Pay date 01 Dec 2021 (Wed) 01 Dec 2022 (Thu)

Enter the number of EKF Diagnostics Holdings plc shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
We have not made any dividend predictions for EKF Diagnostics Holdings plc
Dividend Yield Today
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for EKF Diagnostics Holdings plc
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Forecast Final 31 Oct 2024 28 Nov 2024 GBP Sign up
Forecast Final 02 Nov 2023 30 Nov 2023 GBP Sign up
Forecast Final 03 Nov 2022 01 Dec 2022 GBP Sign up
Paid Final 30 Mar 2021 04 Nov 2021 01 Dec 2021 GBP 1.1p
Paid Final 15 Jul 2019 05 Nov 2020 01 Dec 2020 GBP 1p
Year Amount Change
2006 0.0p
2007 0.0p
2008 0.0p
2009 0.0p
2010 0.0p
2011 0.0p
2012 0.0p
2013 0.0p
2014 0.0p
2015 0.0p
2016 0.0p
2017 0.0p
2018 0.0p
2019 1.0p
2020 1.1p
2021 1.2p
2022 Sign Up Required
2023 Sign Up Required

EKF Diagnostics Holdings plc Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
Optimized Yield
Sign Up Required
52 Week High
4.8% on 12 May 2022
52 Week Low
0.0% on 14 October 2021
Next Ex-Div-Date Countdown
Sign Up Required

About EKF Diagnostics Holdings plc

EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.

Health Care Equipment & Services
United Kingdom
Share Price
£0.35 (yesterday's closing price)
Shares in Issue
464 million
Market Cap
Dividend Cover
How many times is the dividend covered by company income. A cover of 1 means all income is paid out in dividends
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
Market Indices
No articles found